Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6,625 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Combined simultaneous enzymatic saccharification and comminution (SESC) and anaerobic digestion for sustainable biomethane generation from wood lignocellulose and the biochemical characterization of residual sludge solid.
Navarro RR, Otsuka Y, Matsuo K, Sasaki K, Sasaki K, Hori T, Habe H, Nakamura M, Nakashimada Y, Kimbara K, Kato J. Navarro RR, et al. Among authors: sasaki k. Bioresour Technol. 2020 Mar;300:122622. doi: 10.1016/j.biortech.2019.122622. Epub 2019 Dec 14. Bioresour Technol. 2020. PMID: 31891856 Free article.
Yeast cell lysis enhances dimethyl trisulfide formation in sake.
Nishibori N, Sasaki K, Okimori Y, Kanai M, Isogai A, Yamada O, Fujii T, Goto-Yamamoto N. Nishibori N, et al. Among authors: sasaki k. J Biosci Bioeng. 2014 Nov;118(5):526-8. doi: 10.1016/j.jbiosc.2014.04.010. Epub 2014 Jun 3. J Biosci Bioeng. 2014. PMID: 24932967
Eosinophilia During Lenalidomide Therapy in Myelodysplastic Syndrome.
Sasaki K, Kantarjian H, Montalban-Bravo G, Hammond D, Jabbour E, Kanagal-Shamanna R, Chien K, Garcia-Manero G. Sasaki K, et al. Clin Lymphoma Myeloma Leuk. 2024 Apr 18:S2152-2650(24)00169-1. doi: 10.1016/j.clml.2024.04.007. Online ahead of print. Clin Lymphoma Myeloma Leuk. 2024. PMID: 38777652
Asciminib monotherapy in patients with chronic-phase chronic myeloid leukemia with the T315I mutation after ≥1 prior tyrosine kinase inhibitor: 2-year follow-up results.
Cortes JE, Sasaki K, Kim DW, Hughes TP, Etienne G, Mauro MJ, Hochhaus A, Lang F, Heinrich MC, Breccia M, Deininger M, Goh YT, Janssen JJWM, Talpaz M, de Soria VGG, le Coutre P, DeAngelo DJ, Damon A, Cacciatore S, Polydoros F, Agrawal N, Rea D. Cortes JE, et al. Among authors: sasaki k. Leukemia. 2024 May 16. doi: 10.1038/s41375-024-02278-8. Online ahead of print. Leukemia. 2024. PMID: 38755421
6,625 results